Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
While the Company has started to realize some economies of scale in the cost of frames and in the area of shipping and logistics, the cost of prescription lenses has grown disproportionately and significantly more than the Company's revenue, which has had a significant negative impact on gross profit margin. Prescription smart eyewear offered direct-to-consumer has been a key unique selling point used to attract new customers, bringing an important marketing benefit since it is not offered by most of our competitors. We are working with our current prescription lens provider to explore opportunities to reduce costs and we are also actively in discussions with alternative prescription lens suppliers whom we believe may help further lower our lens fulfillment costs. Ultimately, we believe that the majority of our business will come from frame sales to distributors and eyewear retailers, who will outfit lenses themselves for the final customer. We anticipate that the launches of more co-branded products later this year will help us progress towards our long-term goal of shifting our sales mix over time more towards the wholesale channel, which carries higher margins for us as such sales to our third-party retail store partners do not include the cost of prescription lenses.
Finally, as we continue to refine our product mix with sales data, we anticipate further reducing our unit costs by focusing only on the highest volume, market-tested styles.
Units sold increased 150% & Revenue Increased 165% in Q1 2024 vs Q1 2023
The sales growth reported by the Company precedes the launch of three new product lines - Eddie Bauer® Powered by Lucyd, Reebok® Powered by Lucyd, and the Lucyd Armor smart safety glasses line - all of which we are bullish about as they are expected to present additional revenue generating opportunities for us in 2024. In addition, the Company plans to launch new features for the Lucyd app in 2024, including a paid "Pro" version of the app, which will provide another potential incremental revenue stream for the Company from glasses customers.
1st quarter results
https://twitter.com/tekcapital/status/1790368160320811389
I agree re Lucy. There comes a time when you have to call it a day and that time is fast approaching.
The products look great, but if you can't sell at a profit there's no point in being in business. Best hope was always for someone to acquire them, but that's not yet happened.
I think this was written on Friday so a bit old. Also, it has been so frequently covered in UK investor magazine, that i doubt there is any readers who aren't aware of TEK by now.
On this idea of loading up on LUCY i note this guy didn't mention the £6 million cash burn. It looks like a value trap to me. To my mind LUCY is a main reason why TEK trades at such a discount to NAV. Myself and other investors are concerned that TEK will throw increasingly more money down a LUCY black hole.
Morning all
Reading that stockwits thread I have to say, I for one am glad that TEK hasn't purchased any more lucy shares ! so I can't agree with that comment in the slightest. Basically we'd be funding that so definitely not what I'd be wanting TEK to do regardless of how undervalued Lucy stock may appear.
Morning Sea,
There is a thread on Stocktwits echoing your sentiments;
https://stocktwits.com/OrionInvesting/message/572520995
Similar discontent amongst American investors, regarding the Gross (mis)management!! Ha ha 😆
I wonder who's to blame for that ermmmm ok surname ends in G!!
No special dividends after all this time = no trust. Simples.
There defiantly seems to be no trust here.
As expected , UK investor may does a story and we drop always bloodys happens !!
And should give the sp a lift.
Great article for TEK.
Salt boosted by the Shares magazine update IMHO, being mentioned alongside RELX & MSFT as the 3 stocks to follow bodes well.
As mentioned before Cliff is just a 1970s salesman and the sooner he departs the better for all shareholders.
Awaiting news on Guident as 2024 should be their year.
GLA
Morning Mrozzy, Suns out always enhances the mood and this week's boost has helped .
If SALT announces a new deal this coming week we could be in lift off territory, I think many are waiting to make sure they can further move on the big players before committing .
Bell I have no idea if they go on or not
Lucy again god knows but my gut says there doomed , too much cash being burned but hope im wrong
Guidant , IV always said I find this hard to quantify but in all honesty looks pretty dam good and look forward to a revised valuation
AI no one knows yet
Tek is very much undervalued but we know that already , Cliff to blame largely imho and I don't trust him not to bail out his son !!!
Interesting few weeks and months ahead
Altb
Https://open.substack.com/pub/theoakbloke/p/hit-and-miss?r=2k5eki&utm_campaign=post&utm_medium=email
Makes for very compelling reading about TEK
Particularly interesting how he's dug deeper on Guident's AV Day sponsor list that also caught my eye.
Im in profit,but will still hold up until guidents private investment result,surely that will bolster sp ,i do believe guidents assets are not factored into the sp,security robots,this could lead to a lot of profit in the future,
Check out the attendees of the upcoming AV day hosted by Guident and the JTA on 31st May
https://autonomousvehicleday.com/
92p now being paid over at SALT
Yeah if microsalt is worth double the SP same time next year, it would be to sell a small chunk of salt shares to pay Clifford’s salary package. By then we should know the valuation of Guident and possibly listed on the market.
Harold Braun has agreed to do a Revive only interview coming soon.
On the disconnect between TEK and the sum of the parts valuation, while i agree to some extent there are some reasons for this which need more attention.
I am not sure whether LUCY should be seen as an asset and a liability. They had a £6 million cash burn last year, and there access to alternative funding is extremely limited. Is Cliff going to extend TEKs gains to bail out his son?
Cliff's bonus. There are added costs in TEK such as Cliff's outsized pay packet which need to be deducted.
Cliff needs to make an appearance and provide clarity on the undervaluation and answer some important questions that investors have.
I agree. I think we have seen the last of the low SP. I’m actually thinking of topping up. Recession is over, markets seem to agree. The current SP is so out of sync with the valuation of all 4 portfolio companies added together that it will catch on.